What is Artiva Biotherapeutics, Inc.'s stock-based comp?

Artiva Biotherapeutics, Inc. (ARTV) reported stock-based comp of $1.59M in Q1 2026.

How has Artiva Biotherapeutics, Inc.'s stock-based comp changed year-over-year?

Artiva Biotherapeutics, Inc.'s stock-based comp decreased by 22.4% year-over-year, from $2.05M to $1.59M.

What does stock-based comp mean?

Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Artiva Biotherapeutics, Inc. ARTV Stock-Based Comp

Stock-Based Comp at other companies

Bristol-Myers SquibbBMY

$146M+1.4%

Gilead SciencesGILD

$218M+4.3%

Kyverna Therapeutics, Inc.KYTX

$3.17M+46.7%

Allogene TherapeuticsALLO

$8.27M-32.1%

Immix Biopharma, Inc.IMMX

$575.57K-33.7%

ImmunityBio, Inc.IBRX

$8.17M-14.3%

Other financials

Income statement

See full

Revenue-—

Operating income-$24.4M-10.2%

Net income-$23.5M-15.8%

EPS (diluted)-$0.95-14.5%

Balance sheet

See full

Cash & equivalents$21.4M-30.6%

Total debt$10.3M-26.7%

Total equity$87.8M-48.0%

Total assets$106.0M-44.6%

Cash flow

See full

Operating cash flow-$21.0M-5.6%

CapEx$242.0K-52.6%

Free cash flow-$21.2M-4.1%

Valuation

See full

Market cap$429.03M+1,015%

Enterprise value$417.88M+1,832%

Profitability

See full

Operating margin-83.9%—

Net margin-79.3%—

Returns & leverage

See full

Return on equity-67.9%—

Debt / equity0.1×0.0×

Current ratio8.2×-5.8×

Where this comes from

Reported directly by Artiva Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artiva Biotherapeutics, Inc.'s stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Artiva Biotherapeutics, Inc.'s stock-based comp?: Artiva Biotherapeutics, Inc. (ARTV) reported stock-based comp of $1.59M in Q1 2026.
How has Artiva Biotherapeutics, Inc.'s stock-based comp changed year-over-year?: Artiva Biotherapeutics, Inc.'s stock-based comp decreased by 22.4% year-over-year, from $2.05M to $1.59M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.